Comment on “Effectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”

Available evidence suggests MeNZB™ is not associated with a durable effect against N. gonorrhoeae.

Detalles Bibliográficos
Autor principal: Kenyon, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466146/
https://www.ncbi.nlm.nih.gov/pubmed/30875819
http://dx.doi.org/10.3390/vaccines7010031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466146/
https://www.ncbi.nlm.nih.gov/pubmed/30875819
http://dx.doi.org/10.3390/vaccines7010031

Ejemplares similares